Engineering and Development

Management and Executive

Legal and Compliance

Customer Service and Support

Accounting and Finance

Founder, Chief Executive Officer and President

Chief Financial Officer and Executive Vice President, Corporate Strategy

Sanofi Fattens Venture Unit With $625M Infusion for Rare Disease, Neuro Innovation

Transcript : Ultragenyx Pharmaceutical Inc. Presents at Bank of America Global Healthcare Conference 2025, Sep-23-2025 10

Ultragenyx reports inducement grant under Nasdaq

Lysosomal Storage Disorders (LSDs) Market Set to Soar: Key Players Drive Innovative Treatments in 2025-2033

Executive Director, Safety Science, Global DSPV

Ultragenyx is a biopharmaceutical company focused on developing innovative treatments for rare diseases. The Executive Director of Safety Science will lead global safety surveillance and life-cycle management for Ultragenyx products, ensuring compliance with pharmacovigilance regulations while guiding and developing a team of professionals in the field.

Vice President, Global Procurement

Associate Director Global Drug Safety and Pharmacovigilance

Executive Director, Clinical Quality Assurance and GxP Compliance

Senior Director, Global Drug Safety & Pharmacovigilance

Executive Director, Head of Chemical & Pharmaceutical Manufacturing, CMC Lead

Sign up with Google

Sign in with Google